Ma Jingjing and Yin Yeping April 13, 2020
Active pharmaceutical ingredient (API) manufacturers in China are going full speed ahead to produce what US President Donald Trump has called a "game-changer" as well as other APIs to help countries around the world combat the COVID-19 pandemic, as India moves to partially resume exports of two crucial...More
China' s annual exports of $100 billion worth of active pharmaceutical ingredients (API) to the US are encountering disruptions as the coronavirus assault continues, industry insiders said. The US Food and Drug Administration (FDA) issued a statement on Thursday, saying "a (US) manufacturer has alerted us to a...More